“…Successful design of a sensitive and precise immunosensor for detection of protein biomarkers requires careful selection of both binding ligands and signal amplification strategies. − While immunoassays are widely used for detection, sensitivity is limited for many analytes because assay signal generating modes (e.g., enzymatic assays, colorimetric detection, chemiluminescence, and fluorescence) are often difficult to amplify. Recently, DNA strand ligands such as aptamers were developed as alternatives to traditional antibodies for different analyte targets. − While aptamers have the advantages of low cost, easy synthesis, and potential for signal amplification, antibodies remain the most common ligands for biodetection applications , even though DNA-based signal strategies are versatile and easy to amplify. , Immunoassays can be made orders of magnitude more sensitive by replacing the conventionally used enzyme probes with amplifiable DNA probes utilizing polymerase chain reaction (PCR), , rolling circle amplification (RCA), − or hybridization chain reaction (HCR). − Previous efforts have combined the specificity of an immunoassay with DNA-based signal amplification strategies such as immunoassays with PCR (immuno-PCR) and immunoassays with RCA (immuno-RCA). − Although these methods are highly sensitive, they are not widely used because of their complexity. For example, for immuno-PCR, antibodies must be conjugated to the DNA strand, and very precise cycling temperatures are required along with special equipment to detect the amplicon.…”